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Treating Acute Kidney Injury
One Less Weapon in the Armamentarium?
Acute kidney injury (AKI), particularly when accompanied by
critical illness, remains a devastating condition, and recent evidence
consolidates the view that in the critically ill, AKI is associated with
sepsis in more than 50% of cases (1). To date, therapy remains
supportive, with little evidence that any speciﬁc therapy may
inﬂuence outcome. Indeed, this is apparent when one consults
the clinical guidelines for management of AKI, although within
this is the recommendation that protocolized hemodynamic
management for patients with septic shock be adopted (2). It is
therefore timely that in this issue of the Journal, Kellum and
colleagues (pp. 281–287) report the results of the preplanned
ancillary analysis of the ProCESS (Protocolized Care for Early
Septic Shock) trial (3). The authors examine the employment of
protocol-based ﬂuid resuscitation (early goal-directed treatment
[EGDT]) on the development of new-onset AKI of any stage
during the ﬁrst 28 days of enrollment, as well as secondary
outcomes, including duration of AKI, recovery of renal function,
volume overload, and the need for renal support. The results of the
three main studies investigating EGDT in septic shock are well
documented, with no signiﬁcant advantage regarding mortality or
morbidity being observed (4–6). However, they did show that
timely volume resuscitation and delivery of antibiotics to this
patient group appear to have improved dramatically since 2001,
given that the crude mortality in the usual care group was just over
18% compared with the crude mortality of 46.5% observed by
Rivers and colleagues (7). So what of the effect of alternative
resuscitation strategies on AKI in septic shock? Given the absence
of difference in outcome in the main analysis, it is perhaps
unsurprising that no difference is noted with regard to the primary
endpoint of development of new AKI when protocolized care is
used compared with usual care.
However, despite any obvious beneﬁt from EGDT, several
lessons can be learned from this excellently performed study that
may well inform future treatment goals in this patient group.
Clearly, the observed incidence of AKI is in keeping with other
studies in the critically ill, with more than 50% of patients having
AKI at presentation, increasing to almost 70% throughout
admission (1, 8, 9). Therefore, this cohort accurately reﬂects the
case mix commonly seen in intensive care practice. The patients
with, or who develop, AKI have the usual risk factors, including
older age, diabetes, and heart failure, and in particular, those who
present with AKI have a degree of chronic kidney disease and are
more likely to develop positive blood cultures. The severity of
illness of those presenting with AKI on admission appears to be
worse. Do these results then support a nihilistic view with regard to
volume resuscitation in these patients? Clearly not, as the authors
themselves concede. However, the results do suggest that overall
care may have improved with time, and that by the time of
presentation, one is faced with damage limitation with regard to
further organ failure, including AKI, rather than a reversal of the
fundamental pathological processes. Indeed, of those who develop
AKI, most do within a few days of admission, which probably
reﬂects events occurring prehospital; hence, intervention may not
be as fruitful.
A major criticism of many interventional studies on AKI is the
fact that both creatinine and urine output criteria are rarely
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employed, given the perceived difﬁculties in achieving accurate
urine output. This is not the case in this study, where data are robust
and almost complete, with only seven patients excluded from
enrollment. Interestingly, patients who developed AKI after
admission were classiﬁed predominantly on the basis of urine
output criteria, rather than change in serum creatinine. This is of
note, as it may reﬂect an inadequacy to excrete the solute load in
individuals who one assumes are catabolic, and despite the fact that
there is no observed creatinine rise, this still translates into a worse
outcome. Herein lies one of the confounders of AKI diagnosis,
in that creatinine, a robust marker of chronic kidney disease in
relatively stable patients, performs poorly in the acute arena. Thus, a
“rise” in creatinine may be masked by a reduction in creatinine
production that can fall by up to 50% in sepsis (10). This study
highlights the observation that functional change in urine output
may herald signiﬁcant risk, which may have been overlooked
previously and may not be identiﬁed in terms of renal recovery.
Indeed, this study provides further insights into recovery from
sepsis-associated AKI, in that individuals who survive to resolution
of AKI (as deﬁned by a serum creatinine of ,1.5 baseline) appear
to approach the same long-term outcomes as those who did not
suffer AKI. It would be interest to see whether individuals classiﬁed
as having AKI by urine output criteria alone have a similar or
different longer-term risk proﬁle.
So where does that leave the treatment of AKI complicating
septic shock? Clearly initial resuscitation and prompt use of
antibiotic therapy remain the mainstay in treating sepsis, and it is
doubtful that EGDT, even if the protocols are changed slightly, will
result in signiﬁcant improvements. We should consider ﬂuid
therapy as a drug therapy, with more attention given to the
different phases of ﬂuid therapy during the patient’s course of
illness. This includes lifesaving ﬂuid resuscitation in the rescue
phase, titration of ﬂuids to tissue perfusion in the optimization
and stabilization phases, and mobilization of accumulated ﬂuid
in the deescalation phase (11, 12). In addition, the choice of
ﬂuids deserves further study, as cohort studies suggest worse
outcomes for patients resuscitated with unbalanced crystalloid
solutions (13–15). In addition, therapies aimed at restoring
function to near baseline may be the future. This may, of course, be
as simple as avoiding episodes of hypotension, restricting volume,
and avoiding nephrotoxins. Such attention to detail should be
mandatory to avoid the scenario in which renal function is killed,
as perhaps the most sobering statistic from this study is the
appalling outlook for those who do not recover, given a mortality
rate approaching 80% at 28 days. So ﬂuids remain in the
armamentarium of those charged with treating AKI, but
protocolized goal-directed therapy does not seem to be a magic
bullet. n
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